Target intelligence / Profile preview

Actin-binding LIM protein 2 (ABLIM2)

Target
ABLIM2
Molecular classification
Other (actin-binding cytoskeletal protein)
01

Overview

**Actin-binding LIM protein 2 (ABLIM2)** is a cytoskeletal protein that contains LIM domains and a dematin-like domain, enabling it to bind directly to filamentous actin (F-actin)[1][2][4]. It localizes to actin-rich regions, such as stress fibers in muscle and neuronal cells, where it acts as a scaffold integrating cytoskeletal organization with intracellular signaling, and can enhance SRF-dependent transcription by cooperating with proteins such as STARS[2][4]. ABLIM2 exhibits highest expression in brain, retina, and other neuronal tissues, indicating a role in neural function and potentially in retinal development, particularly in photoreceptor cells[2][4]. Although multiple isoforms are expressed in a variety of tissues, the full-length isoform is restricted to the retina[4]. There is currently no evidence that ABLIM2 functions as a classical therapeutic target (receptor, enzyme, transporter, etc.), nor are there known drug interactions or established clinical biomarker applications[1][2][4][5].

Other names
Actin-binding LIM protein family member 2abLIM-2KIAA1808C230091L11LOC100128350testis tissue sperm-binding protein Li 35a
02

Biological functions

Actin filament bindingLamellipodium assemblyScaffold in cytoskeletal organizationPositive regulation of transcription by RNA polymerase IIIntracellular signaling integration
03

Disease associations

Other (currently, no strong associations with major human diseases such as cancer, inflammation, or neurodegenerative diseases have been reported in public databases or literature; potential involvement in neural or retinal function based on tissue expression)

Beyond the preview

Go deeper on Actin-binding LIM protein 2 (ABLIM2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Actin-binding LIM protein 2 (ABLIM2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call